Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

Cancer Epidemiology Biomarkers and Prevention- United States

doi 10.1158/1055-9965.epi-07-2567

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

Hormone Replacement Therapy and the Risk of Endometrial Cancer: A Summary

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Hormone Replacement Therapy and Risk of Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Hormone Replacement Therapy and Survival After Surgery for Ovarian Cancer

International Journal of Gynecology and Obstetrics
MedicineGynecologyObstetrics
1991English

Hormone Replacement Therapy and Survival After Surgery for Ovarian Cancer.

BMJ
1991English

Body Mass Index and Risk of Ovarian Cancer

Cancer
Cancer ResearchOncology
2009English

Novel Breast Cancer Risk Alleles and Endometrial Cancer Risk

International Journal of Cancer
Cancer ResearchOncology
2008English

The Link Between Hormone-Replacement Therapy and Breast Cancer Remains Unclear

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy